ViviCells International, Inc.
VCII
$0.00
$0.000.00%
| 09/30/2000 | 06/30/2000 | 03/31/2000 | |||
|---|---|---|---|---|---|
| Revenue | 714.70K | 2.07M | 2.47M | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | 714.70K | 2.07M | 2.47M | ||
| Cost of Revenue | 152.10K | 1.70M | 1.83M | ||
| Gross Profit | 562.60K | 372.80K | 637.10K | ||
| SG&A Expenses | 227.50K | 231.50K | 157.60K | ||
| Depreciation & Amortization | 5.30K | 4.80K | -- | ||
| Other Operating Expenses | -- | -- | 2.00K | ||
| Total Operating Expenses | 384.90K | 1.94M | 1.99M | ||
| Operating Income | 329.80K | 136.50K | 477.50K | ||
| Income Before Tax | 155.70K | 74.70K | 386.60K | ||
| Income Tax Expenses | 116.90K | -61.00K | 235.30K | ||
| Earnings from Continuing Operations | 38.80K | 135.60K | 151.20K | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | 38.80K | 135.60K | 151.20K | ||
| EBIT | 329.80K | 136.50K | 477.50K | ||
| EBITDA | 335.10K | 141.30K | 483.00K | ||
| EPS Basic | -- | -- | -- | ||
| Normalized Basic EPS | -- | -- | -- | ||
| EPS Diluted | -- | -- | -- | ||
| Normalized Diluted EPS | -- | -- | -- | ||
| Average Basic Shares Outstanding | -- | -- | -- | ||
| Average Diluted Shares Outstanding | -- | -- | -- | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||
